--

DRUGDrugs (Allopathic) under Drugs &Cosmtics ActSubstances and specified devices meant for treatment, mitigation or prevention of diseases or disorders in human beings or animals(whether for external or internal use) including insect repellants and materials used as components of drug and substances intended to affect any structure or function of human body or to destroy vermines and insects causing diseases in human being or animalsDrugs and Magic Remedies (Objectionable Advertisements) Act1951

1991 1905 1907

1956 - - (Foreign Exchange Regulation Act), (Monopolies and Restrictive Trade Practices Act)

1970

1979 374 (Drug Price Control Order)

HIV (zidovudine-Azidothymidine)National Institute of Cancer (USA) - Jerome Horwitz NIC , Burroughs Wellcome (Glax Smithkline) Rtrovir 1987 100 188 , 5-6.5 2005 CIPLA 12000

1994

2005 Process Patent- Product patent 7 20 2004 2001 TRIPS(Trade Related Aspects of intellectual Property Rights) TRIPS PLUS

All India Drug Action Network 2002 2010 2012 348 . 2011

2008 15 .. Good manufacturing practices

Cost based pricing market based pricing MRP MRP

P.H. kurian, IAS, indian patent controller general P.H. Bayer sorafenib tosylate (Nexavar) renal cell carcinoma and hepatocellular carcinoma 3365135 Cipla Natco 105600

3D Chronic Myeloid Leukemia Imatinib Mesylate (glevec) 120000Natco, Cipla, Hotaro 10000 1995 -